Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Logistics Expert and Scholar Michael Curtis Broughton Publishes New Book THE VERONIC INDUSTRIAL STANDARD

August 19, 2026

Luxury NEV Maker SERES Reports 2026 First-Half Results: Revenue of 57.493 Billion Yuan, AITO Deliveries Increased 10.2% YoY

August 19, 2026

Ghost Face Joins Angry Orchard’s Limited-Edition Thriller Variety Pack in New Scream Franchise Collaboration

August 19, 2026

Automox Launches Hosted MCP Server, Expanding AI Access to Endpoint Management

August 19, 2026

Dr. Jacqueline Youtsos Expands Access to Dermatology and Medical Aesthetics with ReNu Medical & Spa in Parsons

August 19, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Pulmera Expands CBeam™ 3D Imaging Platform into Foot and Ankle Surgery
Press Release

Pulmera Expands CBeam™ 3D Imaging Platform into Foot and Ankle Surgery

By News RoomAugust 19, 20264 Mins Read
Pulmera Expands CBeam™ 3D Imaging Platform into Foot and Ankle Surgery
Share
Facebook Twitter LinkedIn Pinterest Email

First four cases span primary and revision ankle replacement and complex foot reconstruction using existing surgical C-arm systems

Pulmera Expands CBeam™ 3D Imaging Platform into Foot and Ankle Surgery

Pulmera, a medical technology company advancing intraoperative imaging, today announced the expansion of its FDA-cleared CBeam™ 3D Imaging Platform into foot and ankle surgery following its initial use at OrthoCarolina in four cases performed by Kent Ellington, MD, FAAOS, Medical Director of the Foot and Ankle Institute at OrthoCarolina. The cases included two primary total ankle replacements, a revision total ankle replacement and a cavus foot reconstruction. Across the procedures, CBeam provided 3D visualization to support intraoperative assessment of deformity correction and implant positioning, as well as postoperative evaluation.

Charlotte, NC, Aug. 19, 2026 (GLOBE NEWSWIRE) — Pulmera, a medical technology company advancing intraoperative imaging, today announced the expansion of its FDA-cleared CBeam™ 3D Imaging Platform into foot and ankle surgery following its initial use at OrthoCarolina in four cases performed by Kent Ellington, MD, FAAOS, Medical Director of the Foot and Ankle Institute at OrthoCarolina.

The cases included two primary total ankle replacements, a revision total ankle replacement and a cavus foot reconstruction. Across the procedures, CBeam provided 3D visualization to support intraoperative assessment of deformity correction and implant positioning, as well as postoperative evaluation. The range of cases represents CBeam’s first application across both joint replacement and complex reconstructive foot and ankle procedures.

CBeam is designed to transform conventional 2D surgical C-arms into intraoperative 3D imaging systems, helping surgical teams visualize complex anatomy during procedures while enabling hospitals to expand access using imaging infrastructure they already own. The platform uses a position-sensor-based system that attaches to widely installed surgical C-arms. During a brief rotational scan, CBeam captures a series of X-ray images and reconstructs them into a 3D dataset, enabling intraoperative visualization to support clinical evaluation, navigation and surgical decision-making.

“In complex foot and ankle surgery, the ability to evaluate anatomy in three dimensions can provide important information about alignment, correction and implant position before the procedure is complete,” said Dr. Ellington. “CBeam allowed us to obtain 3D imaging using the C-arm workflow already familiar to our operating room team, adding another level of visualization to support intraoperative assessment across these different procedures.”

“We’re grateful to Dr. Ellington and the OrthoCarolina team for bringing CBeam into this important area of orthopedic surgery,” said Kevin McGann, CEO of Pulmera. “These cases represent another step in the clinical and commercial progression of CBeam and demonstrate the breadth of procedures that can benefit from intraoperative 3D visualization. Our goal is to make that capability more broadly accessible by leveraging the C-arm infrastructure hospitals already have in place.”

Pulmera plans to continue expanding clinical adoption of CBeam through collaborations with leading surgeons and healthcare institutions as commercialization progresses.

About Pulmera, Inc.
Pulmera, Inc. is a medical technology company focused on advancing intraoperative imaging through its flagship platform, CBeam. The company is developing scalable imaging technology that transforms conventional surgical C-arm systems into intraoperative 3D imaging tools, supporting broader access to advanced surgical visualization and clinical decision-making.

About OrthoCarolina
Since 1922, OrthoCarolina has been a distinguished, physician-owned and physician-led orthopedic practice focused on delivering exceptional, patient-centered care and pioneering solutions. An industry leader in orthopedic treatment, research, and education, OrthoCarolina provides world-class musculoskeletal care across the Carolinas with 40+ locations and nine Orthopedic Urgent Care Centers. OrthoCarolina consistently pushes the boundaries of medical advancement while actively contributing to the training of new specialists and enhancing access to unparalleled orthopedic care. Learn more at orthocarolina.com.

Attachment

  • Pulmera Expands CBeam™ 3D Imaging Platform into Foot and Ankle Surgery
CONTACT: Kevin McGann
Pulmera
(630) 240-3131
[email protected]

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Logistics Expert and Scholar Michael Curtis Broughton Publishes New Book THE VERONIC INDUSTRIAL STANDARD

Luxury NEV Maker SERES Reports 2026 First-Half Results: Revenue of 57.493 Billion Yuan, AITO Deliveries Increased 10.2% YoY

Ghost Face Joins Angry Orchard’s Limited-Edition Thriller Variety Pack in New Scream Franchise Collaboration

Automox Launches Hosted MCP Server, Expanding AI Access to Endpoint Management

Dr. Jacqueline Youtsos Expands Access to Dermatology and Medical Aesthetics with ReNu Medical & Spa in Parsons

DTNA Statement on California Replacement Tire Efficiency Requirements

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Michael Gabelli Establishes National Scholarship Initiative to Support Future Leaders in Civic and Public Service

Dr. Hamid Alam Announces Scholarship for Future Doctors Across the USA

Editors Picks

Luxury NEV Maker SERES Reports 2026 First-Half Results: Revenue of 57.493 Billion Yuan, AITO Deliveries Increased 10.2% YoY

August 19, 2026

Ghost Face Joins Angry Orchard’s Limited-Edition Thriller Variety Pack in New Scream Franchise Collaboration

August 19, 2026

Automox Launches Hosted MCP Server, Expanding AI Access to Endpoint Management

August 19, 2026

Dr. Jacqueline Youtsos Expands Access to Dermatology and Medical Aesthetics with ReNu Medical & Spa in Parsons

August 19, 2026

Latest News

DTNA Statement on California Replacement Tire Efficiency Requirements

August 19, 2026

What is Keystone XL—and why does Trump want to bring it back to life?

August 19, 2026

Moderna’s experimental mRNA cancer treatment progresses, shares spike

August 19, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version